Submission Details
| 510(k) Number | K151421 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 28, 2015 |
| Decision Date | March 10, 2016 |
| Days to Decision | 287 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K151421 is an FDA 510(k) clearance for the Nasal CO2 Sample Line, Oral Nasal CO2 Sampling Cannula, O2 Oral/Nasal Co2 Cannula, Sample Lines, a Analyzer, Gas, Carbon-dioxide, Gaseous-phase (Class II — Special Controls, product code CCK), submitted by Salter Labs (Carlsbad, US). The FDA issued a Cleared decision on March 10, 2016, 287 days after receiving the submission on May 28, 2015. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.1400.
| 510(k) Number | K151421 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 28, 2015 |
| Decision Date | March 10, 2016 |
| Days to Decision | 287 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | CCK — Analyzer, Gas, Carbon-dioxide, Gaseous-phase |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.1400 |